BioFire Diagnostics, LLC
15
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.7%
1 terminated/withdrawn out of 15 trials
91.7%
+5.2% vs industry average
0%
0 trials in Phase 3/4
36%
4 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala
Role: collaborator
Film Array Gastrointestinal Panel Compared to Usual Care for ED Evaluation of Infectious Diarrhea
Role: collaborator
Pathogen Detection and Community Acquired Pneumonia
Role: collaborator
Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department
Role: collaborator
Rapid Detection of Airway Pathogens for Lung Transplantation
Role: collaborator
Specimen Collection and Transport Workflow Evaluations for CLIA-waived Molecular Testing
Role: lead
Implementation of a Molecular Diagnostic for Pediatric Acute Gastroenteritis: The FilmArray GI Panel IMPACT Study
Role: lead
Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel
Role: lead
Collection of Anonymized Samples
Role: lead
Implementation Assessment and Clinical Utility of the FilmArray® Respiratory Panel (RP) EZ in a CLIA-waived Setting
Role: lead
Pilot Evaluation of the FilmArray® Childhood Systemic Infection (CSI) Panel
Role: lead
Prospective Clinical Evaluation of the FilmArray Respiratory Panel 2
Role: lead
Prospective Clinical Evaluation of the FilmArray® NGDS Warrior Panel
Role: lead
Pilot Evaluation of the FilmArray® Febrile Infant (FI) Panel
Role: lead
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Role: lead
All 15 trials loaded